Claire Schvartz

8.9k total citations · 1 hit paper
58 papers, 2.9k citations indexed

About

Claire Schvartz is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Surgery. According to data from OpenAlex, Claire Schvartz has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Oncology and 12 papers in Surgery. Recurrent topics in Claire Schvartz's work include Thyroid Cancer Diagnosis and Treatment (43 papers), Global Cancer Incidence and Screening (12 papers) and Thyroid Disorders and Treatments (11 papers). Claire Schvartz is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (43 papers), Global Cancer Incidence and Screening (12 papers) and Thyroid Disorders and Treatments (11 papers). Claire Schvartz collaborates with scholars based in France, Italy and Belgium. Claire Schvartz's co-authors include Martin Schlumberger, Florent de Vathaire, Marc Colonna, Marie‐Gabrielle Dondon, Pascale Grosclaude, Massimo E. Dottorini, Moncef Abbas, Per Hall, Corrado Rubino and J.E. Couette and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and PLoS ONE.

In The Last Decade

Claire Schvartz

58 papers receiving 2.8k citations

Hit Papers

Strategies of Radioiodine Ablation in Patients with Low-R... 2012 2026 2016 2021 2012 100 200 300 400

Peers

Claire Schvartz
Ka Hee Yi South Korea
Min Ji Jeon South Korea
Catherine Dinauer United States
Claire Schvartz
Citations per year, relative to Claire Schvartz Claire Schvartz (= 1×) peers Livia Lamartina

Countries citing papers authored by Claire Schvartz

Since Specialization
Citations

This map shows the geographic impact of Claire Schvartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Schvartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Schvartz more than expected).

Fields of papers citing papers by Claire Schvartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Schvartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Schvartz. The network helps show where Claire Schvartz may publish in the future.

Co-authorship network of co-authors of Claire Schvartz

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Schvartz. A scholar is included among the top collaborators of Claire Schvartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Schvartz. Claire Schvartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubino, Carolé, Rodrigue S. Allodji, Stéphane Bardet, et al.. (2022). Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment. British Journal of Cancer. 127(12). 2118–2124. 5 indexed citations
2.
Lécuyer, Lucie, Nasser Laouali, Claire Schvartz, et al.. (2021). Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case–control studies. European Journal of Nutrition. 61(2). 1097–1108. 9 indexed citations
3.
Newbold, K., Baktiar Hasan, Laura D. Locati, et al.. (2020). 1919P Nintedanib (BIBF1120) after first line therapy in progressive medullary thyroid cancer: A multicenter EORTC prospective randomized double-blind phase II study (NCT01788982). Annals of Oncology. 31. S1087–S1088. 1 indexed citations
4.
Colonna, Marc, Françoise Borson‐Chazot, Patricia Delafosse, Claire Schvartz, & Anne‐Valérie Guizard. (2020). Progression of incidence and estimate of net survival from papillary thyroid cancers diagnosed between 2008 and 2016 in France. Annales d Endocrinologie. 81(6). 530–538. 12 indexed citations
5.
Tcheandjieu, Catherine, Emilie Cordina‐Duverger, Claire Mulot, et al.. (2020). Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia. PLoS ONE. 15(1). e0228187–e0228187. 5 indexed citations
7.
Schvartz, Claire, et al.. (2019). Micropapillary carcinoma: Description and rise in incidence in the French Marne-Ardennes thyroid cancer registry. Annales d Endocrinologie. 80(4). 229–233. 6 indexed citations
8.
Schlumberger, Martin, Sophie Leboulleux, Bogdan Catargi, et al.. (2018). Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. The Lancet Diabetes & Endocrinology. 6(8). 618–626. 103 indexed citations
9.
Colonna, Marc, Zoé Uhry, Patricia Delafosse, et al.. (2015). Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiology. 39(4). 511–518. 82 indexed citations
10.
Schvartz, Claire, Cécile Dalban, A. Dalac, et al.. (2015). Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Metastatic Differentiated Thyroid Cancers. Clinical Nuclear Medicine. 40(6). 469–475. 26 indexed citations
11.
Bouvier, Anne‐Marie, P. Arveux, Isabelle Baldi, et al.. (2013). What are the delays in providing cancer care in France? A study based on data from cancer registries.. 581–589. 1 indexed citations
12.
Dalac, A., et al.. (2012). Epidemiology of refractory thyroid cancer. 15th International & 14th European Congress of Endocrinology. 29. 2 indexed citations
13.
Schvartz, Claire, Franck Bonnetain, Tienhan Sandrine Dabakuyo‐Yonli, et al.. (2012). Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients. The Journal of Clinical Endocrinology & Metabolism. 97(5). 1526–1535. 164 indexed citations
14.
Rohmer, V., G. Vidal-Trécan, Patricia Niccoli, et al.. (2010). Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d'Etude des Tumeurs Endocrines. The Journal of Clinical Endocrinology & Metabolism. 96(3). E509–E518. 76 indexed citations
15.
Haddy, Nadia, Catherine Paoletti, Marie‐Gabrielle Dondon, et al.. (2009). Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy. Radiotherapy and Oncology. 93(2). 377–382. 14 indexed citations
16.
Colonna, Marc, Arlette Danzon, Patricia Delafosse, et al.. (2007). Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012. European Journal of Cancer. 44(1). 115–122. 57 indexed citations
17.
Carré, Nicolas, Zoé Uhry, Michel Velten, et al.. (2006). Valeur prédictive et sensibilité du programme de médicalisation des systèmes d’information (PMSI) par rapport aux registres des cancers : application au cancer de la thyroïde (1999-2000). Revue d Épidémiologie et de Santé Publique. 54(4). 367–376. 19 indexed citations
18.
Rubino, Corrado, Florent de Vathaire, Massimo E. Dottorini, et al.. (2003). Second primary malignancies in thyroid cancer patients. British Journal of Cancer. 89(9). 1638–1644. 432 indexed citations
20.
Flament, J. B., C. Avisse, Claire Schvartz, et al.. (1993). [Value of parathyroid scintigraphy in preoperative localization of parathyroid adenoma. Study apropos of 138 tests].. PubMed. 119(9). 516–23; discussion 524. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026